Juva Life Announces Filing of Patent on JUVA-041, a Potent Anti-Inflammatory Non-Cannabinoid Molecule Isolated From the Cannabis Plant

The Marijuana Times
By Amanda SafranFeb 4, 2022, 10:41 pm151 pts
Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV), a life science company with pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, has announced the filing of a patent application with the United States Patent and Trademark Office (USPTO) on…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Nevada opens foster parenting to those with cannabis records 41

Exclusive Interview with Josh Kesselman, the New Owner of High Times 25

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.